CS

Charlie Stiefel

Chairman of the Board of Directors at Brickell Biotech

Raleigh, US

About

Prior to joining Brickell, Charles was chairman and CEO of Stiefel Laboratories, Inc. Founded in 1847, Stiefel Laboratories was a family-owned company for more than 160 years until it was sold to GlaxoSmithKline in 2009. At the time, Stiefel Laboratories was the world's largest privately held pharmaceutical company specializing in dermatological products, with nearly 4,000 employees in more than 30 countries and products distributed in more than 100 countries. Charles first joined the company as general counsel in 1982 and was subsequently named executive vice president and then president. In 2003 Charles was awarded a Lifetime Achievement Award by the South Florida Dermatology Foundation, and in 2006 he was named Ernst & Young's Entrepreneur of the Year in Health Sciences for the state of Florida. Born in Catskill, New York, Charles holds an undergraduate degree from Yale University and a JD degree from Albany Law

Position in the VCSift Database

  • 26 investors hold the Chairman of the Board of Directors role in VCSift. Charlie Stiefel is one of them.
  • 295 investors are based in Raleigh, North Carolina, United States.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Stages
seed
Location
Raleigh, US

Contact Information

em••••@example.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Charlie

Search Investors